It has been documented in reviews that, evidence from preclinical studies suggests that Nrg4 may have protective effects in some metabolic disorders such as obesity, NAFLD, and T2DM (Liu and Chen, 2023). The gene discussed is NRG4; the disease is metabolic dysfunction-associated steatotic liver disease.